Elucidating emerging signaling pathways driving endothelial dysfunction in cardiovascular aging

被引:0
|
作者
De Bartolo, Anna [1 ]
Angelone, Tommaso [1 ,2 ]
Rocca, Carmine [1 ,2 ]
机构
[1] Univ Calabria, Dept Biol E&E S DiBEST, Cellular & Mol Cardiovasc Physiol & Pathophysiol L, Cosenza, Italy
[2] Natl Inst Cardiovasc Res INRC, Bologna, Italy
关键词
Aging; Endothelial dysfunction; Inflammaging in cardiovascular aging; Oxidative signaling in vascular dysfunction; Molecular signaling; Cardiovascular disease; SMOOTH-MUSCLE-CELL; RENIN-ANGIOTENSIN SYSTEM; NEUTROPHIL EXTRACELLULAR TRAPS; ACTIVATED PROTEIN-KINASE; OXIDATIVE STRESS; NITRIC-OXIDE; VASCULAR CALCIFICATION; ARTERIAL STIFFNESS; DIETARY NITRATE; MITOCHONDRIAL DYSFUNCTION;
D O I
10.1016/j.vph.2025.107462
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The risk for developing cardiovascular diseases dramatically increases in older individuals, and aging vasculature plays a crucial role in determining their morbidity and mortality. Aging disrupts endothelial balance between vasodilators and vasoconstrictors, impairing function and promoting pathological vascular remodeling. In this Review, we discuss the impact of key and emerging molecular pathways that transduce aberrant inflammatory signals (i.e., chronic low-grade inflammation-inflammaging), oxidative stress, and mitochondrial dysfunction in aging vascular compartment. We focus on the interplay between these events, which contribute to generating a vicious cycle driving the progressive alterations in vascular structure and function during cardiovascular aging. We also discuss the primary role of senescent endothelial cells and vascular smooth muscle cells, and the potential link between vascular and myeloid cells, in impairing plaque stability and promoting the progression of atherosclerosis. The aim of this summary is to provide potential novel insights into targeting these processes for therapeutic benefit.
引用
收藏
页数:22
相关论文
共 50 条
  • [31] Endothelial dysfunction and the kidney: Emerging risk factors for renal insufficiency and cardiovascular outcomes in essential hypertension
    Zoccali, Carmine
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (04): : S61 - S63
  • [32] The Triad: Erectile Dysfunction - Endothelial Dysfunction - Cardiovascular Disease
    Vlachopoulos, Charalambos
    Ioakeimidis, Nikolaos
    Terentes-Printzios, Dimitrios
    Stefanadis, Christodoulos
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (35) : 3700 - 3714
  • [33] Ferulic Acid: Signaling Pathways in Aging
    Neopane, Deepa
    Ansari, Vaseem Ahamad
    Singh, Aditya
    DRUG RESEARCH, 2023, 73 (06) : 318 - 324
  • [34] Microalbuminuria, endothelial dysfunction and cardiovascular risk
    Feldt-Rasmussen, B
    DIABETES & METABOLISM, 2000, 26 : 64 - 66
  • [35] Endothelial dysfunction and cardiovascular risk factors
    Grover-Paez, Fernando
    Zavalza-Gomez, Bertha
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 84 (01) : 1 - 10
  • [36] Cardiovascular syndrome X and endothelial dysfunction
    Vázquez-Rey, E
    Kaski, JC
    REVISTA ESPANOLA DE CARDIOLOGIA, 2003, 56 (02): : 181 - 192
  • [37] Cardiovascular risk factors and endothelial dysfunction
    Wierzbicki, AS
    Chowienczyk, PJ
    Cockcroft, JR
    Brett, SE
    Watts, GF
    Jenkins, BS
    Ritter, JM
    CLINICAL SCIENCE, 2004, 107 (06) : 609 - 615
  • [38] Hypertension, endothelial dysfunction and cardiovascular risk
    Nitenberg, A.
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 2006, 99 (10): : 915 - 921
  • [39] Tetrahydrobiopterin and endothelial dysfunction in cardiovascular diseases
    Shinozaki, K
    Kashiwagi, A
    Masada, M
    Okamura, T
    PTERIDINES, 2006, 17 (01) : 11 - 15
  • [40] Endothelial dysfunction and evaluation of cardiovascular function
    Izumi, Yasukatsu
    Kawaguchi, Hiroaki
    Tawa, Masashi
    Fuchikami, Junichi
    Oka, Mayuko
    Shiota, Masayuki
    Sugiyama, Atsushi
    Okamura, Tomio
    Iwao, Hiroshi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 22P - 22P